Kai Jiang
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Pharmacology top 2%
- Piperaceae Chemical and Biological Studies
Papers in
-
- RNA Interference and Gene Delivery 3
- Oncology 12
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Surgical Treatments 3
- Co-authors
- Kefeng Ding (15 shared papers)Lihua Lai (3 shared papers)Guirong Zheng (6 shared papers)Jingwei Shao (6 shared papers)Lulu Fan (5 shared papers)Xiangxing Kong (5 shared papers)Ruirui Zhao (3 shared papers)Qingqing Wang (2 shared papers)
- Journals
- Frontiers in Oncology (3 papers)IEEE Electron Device Letters (3 papers)Frontiers in Pharmacology (3 papers)Cell Biochemistry and Biophysics (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Kai Jiang
65 papers receiving 2.0k citations
Kai Jiang's Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 397
- Pharmacology 178
- Molecular Biology 957
- Biomaterials 187
- Biotechnology 109
Countries citing papers authored by Kai Jiang
This map shows the geographic impact of Kai Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Jiang more than expected).
Fields of papers citing papers by Kai Jiang
This network shows the impact of papers produced by Kai Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Jiang. The network helps show where Kai Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells Hit paper breakdown → | 2022 | 566 |
| 2 | 2017 | 190 | |
| 3 | 2012 | 182 | |
| 4 | 2021 | 98 | |
| 5 | 2017 | 87 | |
| 6 | 2016 | 64 | |
| 7 | 2014 | 61 | |
| 8 | 2012 | 53 | |
| 9 | 2015 | 53 | |
| 10 | 2019 | 51 | |
| 11 | 2017 | 50 | |
| 12 | 2020 | 43 | |
| 13 | 2017 | 40 | |
| 14 | 2014 | 35 | |
| 15 | 2020 | 34 | |
| 16 | 2018 | 33 | |
| 17 | 2017 | 32 | |
| 18 | 2017 | 26 | |
| 19 | 2019 | 25 | |
| 20 | 2020 | 24 |
About Kai Jiang
Kai Jiang is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Hepatology and Cancer Research, having authored 69 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), RNA Interference and Gene Delivery (3 papers), Colorectal and Anal Carcinomas (3 papers), Lipid metabolism and disorders (3 papers), Cancer-related molecular mechanisms research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). The work is most often cited by research in Cancer Research (397 citations), Pharmacology (178 citations), Molecular Biology (957 citations), Biomaterials (187 citations) and Biotechnology (109 citations). Kai Jiang has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Kefeng Ding, Lihua Lai, Guirong Zheng, Jingwei Shao, Lulu Fan, Xiangxing Kong, Ruirui Zhao, Qingqing Wang, Hongying Ye and Jia He. Their work appears in journals such as Frontiers in Oncology, IEEE Electron Device Letters, Frontiers in Pharmacology, Cell Biochemistry and Biophysics and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.